CD8A and hepatocellular carcinoma: Although previous studies have shown that TPX2 can promote cancer cell proliferation and act as an unfavorable factor in many cancers, we found that low TPX2 levels in CD8+ T cells indicate compromised antitumor immunity in HCC.